You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: March 28, 2024

ABELCET Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


Which patents cover Abelcet, and what generic alternatives are available?

Abelcet is a drug marketed by Leadiant Biosci Inc and is included in one NDA.

The generic ingredient in ABELCET is amphotericin b. There are fifteen drug master file entries for this compound. Five suppliers are listed for this compound. Additional details are available on the amphotericin b profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Abelcet

A generic version of ABELCET was approved as amphotericin b by XGEN PHARMS on April 29th, 1992.

  Try a Trial

US Patents and Regulatory Information for ABELCET

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Leadiant Biosci Inc ABELCET amphotericin b INJECTABLE, LIPID COMPLEX;INJECTION 050724-001 Nov 20, 1995 RX Yes Yes ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for ABELCET

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Leadiant Biosci Inc ABELCET amphotericin b INJECTABLE, LIPID COMPLEX;INJECTION 050724-001 Nov 20, 1995 ⤷  Try a Trial ⤷  Try a Trial
Leadiant Biosci Inc ABELCET amphotericin b INJECTABLE, LIPID COMPLEX;INJECTION 050724-001 Nov 20, 1995 ⤷  Try a Trial ⤷  Try a Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

International Patents for ABELCET

See the table below for patents covering ABELCET around the world.

Country Patent Number Title Estimated Expiration
European Patent Office 0394265 PROCEDE DE SEPARATION GRANULOMETRIQUE DE PARTICULES. (METHOD FOR SIZE SEPARATION OF PARTICLES.) ⤷  Try a Trial
European Patent Office 0282405 Systèmes médicament-lipide à basse toxicité. (Low toxicity drug-lipid systems.) ⤷  Try a Trial
New Zealand 223660 LOW TOXICITY DRUG-LIPID COMPLEXES; METHODS OF MAKING THEM; AND METHOD OF DETERMINING THEIR TOXICITY ⤷  Try a Trial
World Intellectual Property Organization (WIPO) 8905636 ⤷  Try a Trial
Mexico 9203800 SISTEMAS DE DROGA DE BAJA TOXICIDAD-LIPIDO. ⤷  Try a Trial
>Country >Patent Number >Title >Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.